Kwon-Soo Ha Selected Research

dammarenediol

12/2015

Dammarenediol-II Prevents VEGF-Mediated Microvascular Permeability in Diabetic Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kwon-Soo Ha Research Topics

Disease

19	Inflammation (Inflammations) 01/2022 - 07/2004
18	Neoplasms (Cancer) 10/2021 - 01/2005
13	Hyperglycemia 01/2022 - 01/2013
9	Diabetes Complications 01/2022 - 01/2013
9	Vivax Malaria 12/2019 - 12/2010
8	Malaria 03/2022 - 05/2014
5	Pre-Eclampsia (Preeclampsia) 01/2020 - 01/2017
5	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2014
4	Diabetic Retinopathy (Retinopathy, Diabetic) 02/2021 - 01/2014
4	Hypoxia (Hypoxemia) 01/2018 - 02/2007
4	Infections 01/2017 - 11/2011
3	Melanoma (Melanoma, Malignant) 01/2020 - 09/2012
3	Vascular Diseases (Vascular Disease) 01/2020 - 08/2012
3	Atherosclerosis 01/2019 - 01/2012
3	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2017 - 03/2009
3	Urinary Bladder Neoplasms (Bladder Cancer) 10/2011 - 06/2005
2	Colorectal Neoplasms (Colorectal Cancer) 12/2019 - 12/2009
2	Brain Injuries (Brain Injury) 01/2018 - 01/2017
2	Shock 01/2018 - 08/2012
2	Ischemia 01/2015 - 10/2014
2	Experimental Arthritis 07/2008 - 07/2004
2	Arthritis (Polyarthritis) 07/2008 - 07/2004
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Retinal Diseases 02/2021
1	Clonorchiasis 12/2020
1	Body Weight (Weight, Body) 12/2020
1	Metabolic Diseases (Metabolic Disease) 01/2020
1	Diabetes Mellitus 01/2020
1	Schizophrenia (Dementia Praecox) 01/2020
1	Peritonitis 11/2019

Drug/Important Bio-Agent (IBA)

16	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2021 - 02/2007
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2009
10	C-PeptideIBA 01/2022 - 01/2013
6	Pharmaceutical PreparationsIBA 02/2021 - 12/2015
5	AntigensIBA 12/2020 - 05/2014
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2018 - 07/2004
5	TransglutaminasesIBA 05/2018 - 03/2009
5	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2012 - 11/2009
5	NF-kappa B (NF-kB)IBA 01/2009 - 07/2004
4	arginyl-leucyl-tyrosyl-glutamic acidIBA 02/2021 - 02/2017
4	Peptides (Polypeptides)IBA 12/2020 - 01/2013
4	MicroRNAs (MicroRNA)IBA 01/2020 - 12/2014
4	Streptozocin (Streptozotocin)FDA Link 01/2019 - 01/2013
4	CytokinesIBA 12/2018 - 07/2008
4	Photosensitizing Agents (Photosensitizers)IBA 10/2011 - 11/2009
4	chlorinIBA 10/2011 - 11/2009
3	Midazolam (Versed)FDA LinkGeneric 01/2022 - 05/2018
3	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2022 - 01/2013
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 09/2008
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 02/2021 - 02/2017
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 03/2012
3	Insulin (Novolin)FDA Link 11/2019 - 11/2014
3	VaccinesIBA 04/2019 - 12/2010
3	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 12/2018 - 05/2014
3	Heme Oxygenase-1IBA 01/2018 - 12/2014
3	N 30IBA 05/2016 - 10/2015
3	AntioxidantsIBA 01/2015 - 08/2012
3	EnzymesIBA 01/2012 - 03/2009
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2008 - 07/2004
2	Anesthetics (Anesthetic Agents)IBA 01/2022 - 05/2018
2	HydrogelsIBA 01/2022 - 12/2020
2	Therapeutic UsesIBA 02/2021 - 12/2019
2	Blood Glucose (Blood Sugar)IBA 12/2020 - 11/2019
2	NADP (NADPH)IBA 01/2020 - 05/2016
2	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2020 - 05/2016
2	Irinotecan (Camptosar)FDA LinkGeneric 12/2019 - 02/2017
2	Immunoglobulin G (IgG)IBA 04/2019 - 08/2015
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2019 - 02/2017
2	Messenger RNA (mRNA)IBA 12/2018 - 07/2004
2	Carbon MonoxideIBA 01/2018 - 01/2017
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 05/2014
2	Taurine FDA Link 10/2017 - 01/2012
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017 - 05/2014
2	LigandsIBA 10/2016 - 01/2005
2	Small Interfering RNA (siRNA)IBA 01/2016 - 08/2012
2	Caspase 8 (Caspase-8)IBA 01/2014 - 01/2005
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 08/2012 - 01/2010
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 08/2012 - 01/2010
2	LB42708IBA 07/2010 - 07/2004
2	Farnesyltranstransferase (Farnesyltransferase)IBA 07/2010 - 07/2004
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2010 - 01/2010
2	CollagenIBA 07/2008 - 07/2004
2	3,5-dihydroxy-4-methoxybenzoic acidIBA 12/2006 - 10/2006
1	Hemoglobins (Hemoglobin)IBA 03/2022
1	CreatinineIBA 01/2022
1	AlbuminsIBA 01/2022
1	CyclinsIBA 03/2021
1	PlasminogenIBA 02/2021
1	Biopolymers (Biopolymer)IBA 12/2020
1	ElastinIBA 12/2020
1	ziprasidone (Geodon)FDA Link 01/2020
1	erucylphosphocholineIBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 12/2019

Therapy/Procedure

5	Therapeutics 09/2019 - 01/2012
5	Photochemotherapy (Photodynamic Therapy) 04/2012 - 11/2009
3	Intravitreal Injections 05/2018 - 01/2016
1	Drug Therapy (Chemotherapy) 10/2021
1	Subcutaneous Injections 01/2020